CHICAGO - A perennial hot topic in biotech is figuring out how to raise funding. And on day two of the BIO 2010 convention, a panel of five venture capitalists gave audience members a chance to ask questions about how best to position their companies to raise capital.
Eva Jack of MedImmune Ventures noted that, aside from a strong management team and great science, venture capitalists look for companies that are able to differentiate their products from others on the market...